LIVE CONFERENCE: Must be claimed by 12/31/23. https://paceducation.com/CTC23

ENDURING CONFERENCE: Must be claimed by 3/31/24. https://paceducation.com/CTC23Enduring

1. Create an account and fill out your profile using the same email address that you used to register for the conference. 

2. Select the number of credits you earned during the live conference. To calculate your credits, click here

3. Click “Save and continue to Evaluation”

4. Once you have filled out the evaluation form, click “Submit Evaluation”

5. If you need to claim pharmacology credit, you will be able to click on the “Claim ANCC-APRN Certificate button. Screenshot is below

2023 Contraceptive Technology CE Information

• September 20-22,2023 in Atlanta, GA.

• Jointly provided by Partners for Advancing Clinical Education (PACE) and the American Sexual Health Association

Target Audience

This activity is intended for physicians, registered nurses, physician’s associate, physician assistant, nurse practitioner, other APRN.

Educational Objectives

Upon completion of this activity, participants should be able to::

  •  Describe how to access and clinically apply the US Medical Eligibility for Contraceptive Use guideline and it’s app
  • Demonstrate patient centered language for describing an intervention to a patient. 
  • Discuss 2 management options for clients using contraception who experience unacceptable bleeding. 
  • List 2 advantages and 2 disadvantages of contraceptive methods that were FDA approved recently as compared to older contraceptive methods. 
  • Explain how to address contraception needs and preferences for clients with chronic medical conditions; lupus, obesity, bleeding disorders, substance use disorders, and cardiac conditions 

Disclosure of Conflicts of Interest

PACE requires planners, faculty, and others who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships aare thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following financial relationships or relationships to products or devices they have with ineligible companies:

FacultyConflicts of Interest
Kelechukwu Anyanwu MD Moorehouse College of Medicine   Has no relevant financial relationships with ineligible companies to disclose
​Debbie Bamberger, DNP, MS, WHNP-BC Planned ParenthoodHas no relevant financial relationships with ineligible companies to disclose
​Amy Boone, MD​ University of Alabama School of medicineHas no relevant financial relationships with ineligible companies to disclose
Pam Brooks-Crump, MBA Georgia Mental Health Consumer NetworkHas no relevant financial relationships with ineligible companies to disclose
Patty Cason, NP Envision SRH, UCLA School of NursingMerck -speaker on non-branded topic Sebela Women’s Health -Consultant IUD trainer Organon -Implant trainer
Megan Cohen, MD Planned ParenthoodHas no relevant financial relationships with ineligible companies to disclose
Carrie Cwiak, MD Emory University School of MedicineSebela Women’s Health -researcher Springer -Textbook on contraception royalties, patent beneficiary
Alison Edelman, MD University of Oregon School of MedicineHRA pharma -University receives research funds Organon -University receives research funds Gynuity – Consultant Contraceptive Technology Corporation- Royalties Up to Date -Royalties
Ian Fields, MD University of Oregon School of MedicineHas no relevant financial relationships with ineligible companies to disclose
Marshll Fleurant, MD Emory University School of MedicineHas no relevant financial relationships with ineligible companies to disclose
Lisa Flowers, MD Emory University School of MedicineHas no relevant financial relationships with ineligible companies to disclose
Diana Greene Foster PhD University of California San FranciscoHas no relevant financial relationships with ineligible companies to disclose
Daniel Grossman, MD University of California San Francisco School of MedicineHas no relevant financial relationships with ineligible companies to disclose
Tiffany Hailstorks, MD Emory University School of MedicineHas no relevant financial relationships with ineligible companies to disclose
Katherine Hill, MD Equip HealthHas no relevant financial relationships with ineligible companies to disclose
Samantha V. Hill, MD, MPH University of Alabama at Birmingham School of MedicineClinical Care Options -Consultant, speaker ​
Missy Kottke, MD  Grady HealthHRA Pharma -Consultant, Speaker Organon -Researcher
Chance Krempasky, NP Callen-Lorde Community Health CenterHas no relevant financial relationships with ineligible companies to disclose
Meg Lawley, MD Emory University School of MedicineHas no relevant financial relationships with ineligible companies to disclose
Anna Maria Maples, MD Emory University School of MedicineHas no relevant financial relationships with ineligible companies to disclose
Taniqua Miller, MD MD Emory University School of MedicineHerMD -Consultant
Subasri Narasimhan, PhD, MPH​ Emory University School of MedicineHas no relevant financial relationships with ineligible companies to disclose
Anita Nelson, MD David Geffen School of Medicine at UCLAMylan Pharmaceuticals -Researcher Myovant Sciences – Researcher and Consultant Organon – Researcher Sagami Rubber Industries -Researcher Sebela Women’s Health – Researcher Agile Theraputics -Speaker and Consultant Bayer Health Care –Speaker and Consultant Mayne Pharmaceutical –Speaker and Consultant Merck –Speaker Organono –Speaker    
Ina Park, MD University of California San Francisco School of MedicineHas no relevant financial relationships with ineligible companies to disclose
Michael Policar, MD University of California San Francisco School of MedicineHas no relevant financial relationships with ineligible companies to disclose
Chelsea Polis, PhD Population CouncilPopulation Council Employee
Joely Pritzker, NP  Vista Community ClinicOrganon -Implant trainer
Whitney Rice, MD Emory University Rollins School of Public HealthHas no relevant financial relationships with ineligible companies to disclose
David A. Schirmer III, MD Emory University School of MedicineHas no relevant financial relationships with ineligible companies to disclose
Pam Brooks-Crump, MBA Georgia Mental Health Consumer NetwokHas no relevant financial relationships with ineligible companies to disclose
​Angeline Ti, MD​ Emory University School of MedicineHas no relevant financial relationships with ineligible companies to disclose
David Turok, MD University of Utah School of MedicineBayer -Researcher Sebela Women’s Health Consultant, Speaker Organon -Researcher Cooper Surgical -Researcher Myovant -Consultant, Speaker Medicines 360 -Researcher
Olivia  Van Gerwen, MD University of Alabama School of medicine​​Gilead Sciences Inc​ -Researcher Abbott Molecular -Researcher
Nisha Verma MD Emory University School of MedicineHas no relevant financial relationships with ineligible companies to disclose

Program Agenda: https://www.eventleaf.com/e/CT2023

Americans with Disabilities Act 

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact ASHA prior to the live event at conference@ashasexualhealth.org.

Fee Information

Registartion is required to participate in this activity. Please click here for registration information.

Joint Accreditation Statement 

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and The American Sexual Health Association (ASHA).  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

PACE designates this enduring activity for a maximum of 47 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 47 contact hours and 10 pharmacology credit hours.